MARSHALL WACE, LLP

Position in ADMA — Adma Biologics, Inc.

CIK 1318757 LONDON, X0

Position in ADMA

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$2,571,715

+$2,187,667 QoQ

Shares Held

307,254

+1356.9% QoQ

Ownership

0.137%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#71

of 323 holders

Holding Since

Mar 2020

10 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Jun 30, 2026

MARSHALL WACE, LLP holds $3,014,740,742 across 267 Biotechnology names. ADMA ranks #130 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	543,897	$270,169,956
2	INCY	Incyte Corp	1,310,154	$148,519,056
3	RPRX	Royalty Pharma plc	2,450,669	$137,409,009
4	SYRE	Spyre Therapeutics, Inc.	991,693	$88,042,503
5	ALNY	Alnylam Pharmaceuticals, Inc.	259,799	$78,207,292
6	TVTX	Travere Therapeutics, Inc.	1,333,207	$75,739,488
7	MANE	Veradermics, Inc	585,560	$71,988,746
8	DFTX	Definium Therapeutics, Inc.	1,298,946	$61,102,419

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,571,715	307,254	+1356.9%	Shares	Other	2026-08-13
2025-06-30	$384,048	21,090	-21.3%	Shares	Other	2025-08-13
2024-06-30	$299,624	26,800	+44.1%	Shares	Other	2024-08-14
2024-03-31	$122,740	18,597	-87.0%	Shares	Other	2024-05-15
2023-09-30	$513,654	143,479	+24.9%	Shares	Other	2023-11-14
2023-03-31	$380,319	114,900	-95.4%	Shares	Other	2023-05-15
2020-12-31	$4,857,255	2,490,900	0.0%	Shares	Sole	2021-02-16
2020-09-30	$5,953,251	2,490,900	+174.0%	Shares	Sole	2020-11-16
2020-06-30	$2,663,153	908,926	+5.4%	Shares	Sole	2020-08-13
2020-03-31	$2,483,688	862,392	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.